Logo do repositório
 
Publicação

Potential roles of inflammatory miRNAs and exosomes in Alzheimer’s disease pathogenesis, diagnostics and therapeutics using advanced Human models

2022-05Tese de doutoramento Acesso aberto
Ver registo simples
datacite.subject.fosCiências Médicas::Medicina Básicapt_PT
dc.contributor.advisorBrites, Dora Maria Tuna de Oliveira
dc.contributor.advisorMalm, Tarja Maarit
dc.contributor.authorGarcia, Gonçalo
dc.date.accessioned2022-10-26T09:18:49Z
dc.date.available2025-06-01T00:31:08Z
dc.date.issued2022-05
dc.date.submitted2022-03
dc.description.abstractAlzheimer’s disease (AD) is a complex brain disorder with a heavy socio-economic burden, affecting over 50 million people worldwide. Although aging, genetics and environmental factors constitute major risk factors, alterations in neuron-glia communication and dysregulation of microRNAs (miRNAs) dysregulation were shown to be key players in AD pathogenesis. The neural-specific miRNA(miR)-124 is a prominent player in neuronal function. We identified its consistent upregulation in SH-SY5Y-APP695 Swedish neuroblastoma cells (SH-SWE) and PSEN1 mutant iPSC-derived neurons (iNEU-PSEN), as well as in their respective exosomes. Considering the controversy around miR-124 in AD, we investigated the outcomes of modulating its levels in both neuronal cells, using specific miR-124 inhibitor/mimic. Results demonstrated that the mimic reduced APP gene expression in both models of AD. Moreover, it stimulated neurite outgrowth, mitochondria membrane potential and reduced small Aβ oligomers in SH-SWE neurons, while it inhibited tau phosphorylation in iNEU-PSEN cells. Besides, miR-124 mimic predominantly repressed the inflammatory-associated miR-125b/miR-21/miR-146a/miR-155. Oppositely, miR-124 inhibitor prompted miR-146a in the two neuronal models, while it reduced neurite outgrowth and affected mitochondrial dynamics in SH-SWE cells, and decreased dendritic spine density in iNEU-PSEN. Thereafter, we evaluated the paracrine influence of the neuronal miR-124 modulation on microglial polarization status, under an inflammatory milieu. For that, we co-cultured miR-124 modulated SWE cells with the human CHME3 microglia stimulated with interferon gamma (IFNγ-MG). Results evidenced that besides the benefits for SWE cells, miR-124 mimic reduced microglial activation (downregulated TNF-α/iNOS), inhibited extracellular MMP-2/MMP-9 activity, and led to proteomic downregulation of 72 proteins (e.g., MAP2K6) and upregulation of 21 (e.g., PAWR). In contrast, miR-124 inhibition favored microglial inflammatory signature (upregulated RAGE/HMGB1/iNOS/IL-1β; downregulated IL-10/ARG-1) and led to proteomic changes favoring the IFNγ-induced signature (e.g., TGFB1 downregulation). By blocking miRNA canonical biogenesis through Dicer1-silencing, we confirmed miR-124 uptake by microglia upon coculture with SWE cells, and upon incubation with SWE-derived exosomes. Finally, we analyzed the miRNA expression profile in cerebrospinal fluid (CSF) samples from a small cohort of Mild Cognitive Impairment (MCI) patients and specifically detected miR-21 elevation in samples from patients that progressed to AD, comparatively to those that didn’t. Such miR-21 elevation was confirmed and cross-validated in AD patient iPSC-derived microglia, neurons, and astrocytes. We further developed a new organotypic hippocampal slice model transplanted with SH or SWE cells. Remarkably, transplantation of SWE cells into hippocampal slices boosted the miR-21 expression and induced both microglia activation and astrocyte reactivity, validating the active role of miR-21 in AD. Overall, our studies support that miR-124 is a promising target with pleiotropic effects, from APP processing and maintenance of dendritic homeostasis to the reshaping of microglial plasticity in AD-associated context and should be regulated whenever necessary. Furthermore, we elucidated the potential of miR-21 as a promising disease-modifying miRNA to be explored in AD, considering its involvement in neuronal dysfunction, microglia activation, and astrocyte reactivity. Together, the novel insights provided in this Thesis may pave the way for the development of future personalized neuropharmacological strategies with miRNAs, either in the secretome or as cargo of exosomes.pt_PT
dc.description.provenanceSubmitted by Paula Guerreiro (passarinho@reitoria.ulisboa.pt) on 2022-10-14T14:26:52Z No. of bitstreams: 1 scnd740046_td_Gonçalo_Garcia.pdf: 9988929 bytes, checksum: ae344d5f873fe54edddea5c7c03dd34d (MD5)en
dc.description.provenanceMade available in DSpace on 2022-10-26T09:18:49Z (GMT). No. of bitstreams: 1 scnd740046_td_Gonçalo_Garcia.pdf: 9988929 bytes, checksum: ae344d5f873fe54edddea5c7c03dd34d (MD5) Previous issue date: 2022-05en
dc.identifier.tid101628307pt_PT
dc.identifier.urihttp://hdl.handle.net/10451/54907
dc.language.isoengpt_PT
dc.relationJPco-fuND/0003/2015pt_PT
dc.relationRole of neural exosomes on microglia activation/dysfunction using AD cell line models and AD iPSCs-derived neurons and astrocytes in 2D/3D culture systems
dc.relationRole of neural exosomes on microglia activation/dysfunction using AD cell line models and AD iPSCs-derived neurons and astrocytes in 2D/3D culture systems
dc.relationDevelopment of an autologous exosome-based therapy by engineering microRNAs in microglia and motor-neurons using mice and human models of amyotrophic lateral sclerosis (ALS)
dc.relationResearch Institute for Medicines
dc.subjectModelos celulares de doença de Alzheimer (DA)pt_PT
dc.subjectimico/inibidor do miR-124-3ppt_PT
dc.subjectSobre-expressão do miR-21-5ppt_PT
dc.subjecteurónios/astrócitos/microglia diferenciados de iPSCs de doentes ADpt_PT
dc.subjectSinalização parácrina mediada pelo(s) secretoma/exossomas (pequenas vesiculas extracelulares)pt_PT
dc.subjectAlzheimer’s disease (AD) modelingpt_PT
dc.subjectmiR-124-3p inhibitor/mimicpt_PT
dc.subjectmiR-21-5p upregulationpt_PT
dc.subjectAD patient-specific iPSC-derived neurons/astrocytes/microgliapt_PT
dc.subjectsecretome/exosome (small extracellular vesicles) paracrine signalingpt_PT
dc.titlePotential roles of inflammatory miRNAs and exosomes in Alzheimer’s disease pathogenesis, diagnostics and therapeutics using advanced Human modelspt_PT
dc.typedoctoral thesis
dspace.entity.typePublication
oaire.awardTitleRole of neural exosomes on microglia activation/dysfunction using AD cell line models and AD iPSCs-derived neurons and astrocytes in 2D/3D culture systems
oaire.awardTitleRole of neural exosomes on microglia activation/dysfunction using AD cell line models and AD iPSCs-derived neurons and astrocytes in 2D/3D culture systems
oaire.awardTitleDevelopment of an autologous exosome-based therapy by engineering microRNAs in microglia and motor-neurons using mice and human models of amyotrophic lateral sclerosis (ALS)
oaire.awardTitleResearch Institute for Medicines
oaire.awardURIinfo:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F128738%2F2017/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/OE/COVID%2FBD%2F151849%2F2021/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/9471 - RIDTI/PTDC%2FMED-NEU%2F31395%2F2017/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FDTP%2F04138%2F2019/PT
oaire.fundingStreamOE
oaire.fundingStream9471 - RIDTI
oaire.fundingStream6817 - DCRRNI ID
person.familyNameGarcia
person.givenNameGonçalo
person.identifier695914
person.identifier.ciencia-idD31E-5043-D433
person.identifier.orcid0000-0001-5526-5362
person.identifier.scopus-author-id57190496766
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.contributor.authoremailrepositorio@reitoria.ulisboa.pt
rcaap.rightsopenAccesspt_PT
rcaap.typedoctoralThesispt_PT
relation.isAuthorOfPublicationff90fea2-35b3-4fac-add6-1956262c7e96
relation.isAuthorOfPublication.latestForDiscoveryff90fea2-35b3-4fac-add6-1956262c7e96
relation.isProjectOfPublication8b69096c-f3c2-4a67-be81-ff39e427a46f
relation.isProjectOfPublicationbaefccd2-ad3a-40b7-ba68-6bbdea6725c8
relation.isProjectOfPublication0eb70aed-a985-483f-806e-265eff7e8192
relation.isProjectOfPublicationf7ed2a0a-c67e-4c12-ad63-b550724e24bf
relation.isProjectOfPublication.latestForDiscoverybaefccd2-ad3a-40b7-ba68-6bbdea6725c8
thesis.degree.nameTese de doutoramento, Farmácia (Biologia Celular e Molecular), Universidade de Lisboa, Faculdade de Farmácia, 2022pt_PT

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
scnd740046_td_Gonçalo_Garcia.pdf
Tamanho:
9.53 MB
Formato:
Adobe Portable Document Format
Ver/Abrir
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Ver/Abrir

Coleções